760
Participants
Start Date
December 31, 2015
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
mOPV2 at 6 and 7 weeks of age
Participants assigned to this intervention will receive a dose of monovalent oral type 2 polio vaccine (mOPV2) at 6 and 7 weeks of age
mOPV2 at 6 and 8 weeks of age
Participants assigned to this intervention will receive a dose of monovalent oral type 2 polio vaccine (mOPV2) at 6 and 8 weeks of age
mOPV2 at 6 and 10 weeks of age
Participants assigned to this intervention will receive a dose of monovalent oral type 2 polio vaccine (mOPV2) at 6 and 10 weeks of age
IPV at 6 weeks of age
Participants assigned to this intervention will receive a dose of inactivated polio vaccine (IPV) 6 weeks of age
International Center for Diarrhoeal Disease Research, Bangladesh, Dhaka
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
Centers for Disease Control and Prevention
FED